Section of Pharmacology, Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.
Int J Mol Sci. 2023 Mar 4;24(5):4976. doi: 10.3390/ijms24054976.
Ultrasonography is a safe, non-invasive imaging technique used in several fields of medicine, offering the possibility to longitudinally monitor disease progression and treatment efficacy over time. This is particularly useful when a close follow-up is required, or in patients with pacemakers (not suitable for magnetic resonance imaging). By virtue of these advantages, ultrasonography is commonly used to detect multiple skeletal muscle structural and functional parameters in sports medicine, as well as in neuromuscular disorders, e.g., myotonic dystrophy and Duchenne muscular dystrophy (DMD). The recent development of high-resolution ultrasound devices allowed the use of this technique in preclinical settings, particularly for echocardiographic assessments that make use of specific guidelines, currently lacking for skeletal muscle measurements. In this review, we describe the state of the art for ultrasound skeletal muscle applications in preclinical studies conducted in small rodents, aiming to provide the scientific community with necessary information to support an independent validation of these procedures for the achievement of standard protocols and reference values useful in translational research on neuromuscular disorders.
超声成像是一种安全、非侵入性的医学成像技术,可用于多个医学领域,能够随时间纵向监测疾病的进展和治疗效果。当需要密切随访或在装有起搏器的患者(不适合磁共振成像)中时,这尤其有用。由于这些优势,超声检查常用于运动医学中检测多种骨骼肌结构和功能参数,以及神经肌肉疾病,例如肌强直性营养不良和杜氏肌营养不良症(DMD)。高分辨率超声设备的最新发展使得该技术可用于临床前研究,特别是用于超声心动图评估,目前尚缺乏针对骨骼肌测量的具体指南。在这篇综述中,我们描述了在小型啮齿动物中进行的临床前研究中超声骨骼肌应用的最新技术,旨在为科学界提供必要的信息,以支持对这些程序进行独立验证,从而制定用于神经肌肉疾病转化研究的标准方案和参考值。